Log in to save to my catalogue

Advances in molecular biomarkers research and clinical application progress for gastric cancer immun...

Advances in molecular biomarkers research and clinical application progress for gastric cancer immun...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_17083cf6e53d430383d74a92d2be4461

Advances in molecular biomarkers research and clinical application progress for gastric cancer immunotherapy

About this item

Full title

Advances in molecular biomarkers research and clinical application progress for gastric cancer immunotherapy

Publisher

London: BioMed Central Ltd

Journal title

Biomarker research, 2022-08, Vol.10 (1), p.1-67, Article 67

Language

English

Formats

Publication information

Publisher

London: BioMed Central Ltd

More information

Scope and Contents

Contents

Gastric cancer is characterized by high morbidity and mortality worldwide. Early-stage gastric cancer is mainly treated with surgery, while for advanced gastric cancer, the current treatment options remain insufficient. In the 2022 NCCN Guidelines for Gastric Cancer, immunotherapy is listed as a first-line option for certain conditions. Immunothera...

Alternative Titles

Full title

Advances in molecular biomarkers research and clinical application progress for gastric cancer immunotherapy

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_17083cf6e53d430383d74a92d2be4461

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_17083cf6e53d430383d74a92d2be4461

Other Identifiers

ISSN

2050-7771

E-ISSN

2050-7771

DOI

10.1186/s40364-022-00413-0

How to access this item